![]() Within categories, Torics grew 15%, Multifocals grew 18%, Single-use Sphere grew 7%, and Non-Single-use Sphere, other grew 4%. With all three regions having success with our innovative products, market-leading flexibility and growth in key accounts. The Americas grew 12%, EMEA grew 9%, and Asia Pac grew 10%. For CooperVision, and reporting all percentages on an organic basis, revenue growth was strong and diversified. Margins improved and profits were solid with non-GAAP earnings per share of $3.47, up 26%. CooperVision’s growth was led by strength in our daily silicone hydrogel portfolio, and CooperSurgical’s growth was led by a very strong quarter in our fertility business. CooperVision posted revenues of $623 million, up 11% organically, and CooperSurgical posted revenues of $304 million, up 7% organically. Moving to the quarterly numbers, consolidated revenues were $927 million, up 9% organically year-over-year. We’ve now entered Fiscal 2024 with a lot of excitement and focus on executing on our long-range strategic objectives, including gaining market share, driving profitability, launching innovative products and services, and maintaining our fantastic Cooper culture. Truly tremendous accomplishments by phenomenal teams. This was a fantastic year for Cooper as we finished with all-time record revenues of almost $3.6 billion, and we closed the year on a really positive note with CooperVision posting its 11th consecutive quarter of double-digit organic growth and CooperSurgical posting record quarterly revenues driven by our fertility business posting its 12th consecutive quarter of double-digit organic growth. Should you have any additional questions following the call, please e-mail: And now I'll turn the call over to Al for his opening remarks.Īlbert White: Thank you, Kim, and welcome everyone to Cooper Company’s 2023 Fiscal Fourth Quarter and Year-End Conference Call. We encourage you to consider our results under GAAP as well as under non-GAAP and refer to the reconciliations provided in our earnings release, which is available on the Investor Relations section of our website under quarterly materials. Also, as a reminder, the non-GAAP financial information we will provide on this call is provided as a supplement to our GAAP information. Events that could cause our actual results and future actions of the company to differ materially from those described in forward-looking statements are set forth under the caption forward-looking statements in today’s earnings release and are described in our SEC filings including Cooper’s Form 10-K and Form 10-Q filings, all of which are available on our website at. Before we begin, I’d like to remind you that this conference call contains forward-looking statements including revenue, EPS, operating income, tax rate, and other financial guidance, a pending stock split, expected revenue growth and accretion related to a recent acquisition, strategic and operational initiatives, market and regulatory conditions and trends, and product launches and demand.įorward-looking statements depend on assumptions, data, or methods that may be incorrect or imprecise and are subject to risks and uncertainties. ![]() Our presenters on today’s call are Al White, President and Chief Executive Officer, and Brian Andrews, Chief Financial Officer and Treasurer. During today’s call, we will discuss the results and guidance included in the earnings release and then use the remaining time for questions. Good afternoon and welcome to Cooper Companies’ Fourth Quarter and Full Year 2023 Earnings Conference Call. I would now like to welcome Kim Duncan, VP Investor Relations and Risk Management to begin the call. Operator: Thank you for standing by and welcome to the Q4 2023 Cooper Companies Earnings Conference Call. Reported EPS is $3.47 EPS, expectations were $3.47. reports earnings inline with expectations. (NYSE: COO) Q4 2023 Earnings Call Transcript December 7, 2023
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |